{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:00:11Z","timestamp":1786737611884,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Vector Borne Dis"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/0972-9062.308805","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T09:40:17Z","timestamp":1616492417000},"page":"78","source":"Crossref","is-referenced-by-count":2,"title":["Study of the in vitro and in vivo antileishmanial activities of nimodipine in susceptible BALB\/c mice"],"prefix":"10.4103","volume":"57","author":[{"given":"MahmoudReza","family":"Jaafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Azadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Alipour-Talesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammadJavad","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeyedehHoda","family":"Alavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Banihashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0972-9062.308805-1","first-page":"203\u201311","volume-title":"Cutaneous leishmaniasis","author":"Bailey","year":"2007","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/0972-9062.308805-2","first-page":"1561\u201377","volume-title":"Advances in leishmaniasis","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"key-10.4103\/0972-9062.308805-3","first-page":"50\u20134","volume-title":"Some epidemiological aspects of cutaneous leishmaniasis in Northern Khorasan Province, Iran","author":"Alavinia","year":"2009","journal-title":"Iran J Arthropod Borne Dis"},{"key":"key-10.4103\/0972-9062.308805-4","first-page":"557\u201361","volume-title":"Leishmaniasis recidivans among school children in Bam, Southeast Iran, 1994\u20132006","author":"Sharifi","year":"2010","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0972-9062.308805-5","first-page":"24\u201345","volume-title":"Diagnosis and treatment of leishmaniasis: Clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","author":"Aronson","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0972-9062.308805-6","first-page":"16092","volume-title":"Drug resistance in eukaryotic microorganisms","author":"Fairlamb","year":"2016","journal-title":"Nat Microbiol"},{"key":"key-10.4103\/0972-9062.308805-7","first-page":"e162","volume-title":"Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites","author":"Hadighi","year":"2006","journal-title":"PLoS Med"},{"key":"key-10.4103\/0972-9062.308805-8","first-page":"744\u201366","volume-title":"Nimodipine and its use in cerebrovascular disease: Evidence from recent preclinical and controlled clinical studies","author":"Tomassoni","year":"2008","journal-title":"Clin Exp Hyperten"},{"key":"key-10.4103\/0972-9062.308805-9","first-page":"103\u20138","volume-title":"Leishmania donovani: Effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate","author":"Valiathan","year":"2006","journal-title":"Exp Parasitol"},{"key":"key-10.4103\/0972-9062.308805-10","first-page":"1113\u20137","volume-title":"The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate","author":"Shokri","year":"2012","journal-title":"Parasitol Res"},{"key":"key-10.4103\/0972-9062.308805-11","first-page":"197\u20138","volume-title":"Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil","author":"Neal","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/0972-9062.308805-12","first-page":"499\u2013505","volume-title":"Antileishmanial activity and ultrastructural alterations of Leishmania (L.) chagasi treated with the calcium channel blocker Nimodipine","author":"Tempone","year":"2009","journal-title":"Parasitol Res"},{"key":"key-10.4103\/0972-9062.308805-13","first-page":"111\u20135","volume-title":"In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: Detection of viable Leishmania (L.) chagasi by real-time PCR","author":"Reim\u00e3o","year":"2011","journal-title":"Exp Parasitol"},{"key":"key-10.4103\/0972-9062.308805-14","first-page":"8044\u201353","volume-title":"Antileishmanial and anti-trypanosomal activities of 1, 4-dihydropyridines: In vitro evaluation and structure-activity relationship study","author":"Reim\u00e3o","year":"2010","journal-title":"BioorganicMed Chem"},{"key":"key-10.4103\/0972-9062.308805-15","first-page":"243\u20138","volume-title":"A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis","author":"Yardley","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0972-9062.308805-16","first-page":"119\u201322","volume-title":"Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis","author":"Dutta","year":"2005","journal-title":"Parasitol Int"},{"key":"key-10.4103\/0972-9062.308805-17","first-page":"2259\u201365","volume-title":"Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB\/c mice","author":"Jaafari","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0972-9062.308805-18","first-page":"545\u201355","volume-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","author":"Titus","year":"1985","journal-title":"Parasit Immunol"},{"key":"key-10.4103\/0972-9062.308805-19","first-page":"941\u201351","volume-title":"Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B","author":"Smith","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0972-9062.308805-20","first-page":"6107\u201317","volume-title":"The role of CpG ODN in enhancement of immune response and protection in BALB\/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome","author":"Jaafari","year":"2007","journal-title":"Vaccine"},{"key":"key-10.4103\/0972-9062.308805-21","first-page":"5708\u201317","volume-title":"Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB\/c mice","author":"Jaafari","year":"2006","journal-title":"Vaccine"},{"key":"key-10.4103\/0972-9062.308805-22","first-page":"13\u20138","volume-title":"Role of Ca2+ ion on Leishmania-macrophage attachment","author":"Misra","year":"1991","journal-title":"Mol Cell Biochem"},{"key":"key-10.4103\/0972-9062.308805-23","first-page":"374\u20137","volume-title":"Oral therapy with amlodipine and lacidipine, 1, 4-dihydropyridine derivatives showing activity against experimental visceral leishmaniasis","author":"Palit","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0972-9062.308805-24","first-page":"5\u201310","volume-title":"Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L.major lesion in BALB\/c mice","author":"Kalat","year":"2014","journal-title":"Exp Parasitol"},{"key":"key-10.4103\/0972-9062.308805-25","first-page":"163\u201372","volume-title":"Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a distigmasteryl hemisuccinoylglycero-phosphocholine liposome-intercalated amphotericin B","author":"Iman","year":"2011","journal-title":"Int J Pharm"},{"key":"key-10.4103\/0972-9062.308805-26","first-page":"899\u2013905","volume-title":"Monitoring drug resistance in leishmaniasis","author":"Croft","year":"2001","journal-title":"Trop Med Int Health"},{"key":"key-10.4103\/0972-9062.308805-27","first-page":"581\u201392","volume-title":"Cutaneous leishmaniasis: Immune responses in protection and pathogenesis","author":"Scott","year":"2016","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:56:47Z","timestamp":1786733807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-9062.308805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["308805"],"URL":"https:\/\/doi.org\/10.4103\/0972-9062.308805","relation":{},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}